2018-2023 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Report (Status and Outlook)

October 2018 | 118 pages | ID: 2D916B67538EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Recurrent Glioblastoma Multiforme (GBM) Treatment market for 2018-2023.
Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.
The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market.

Over the next five years, LPI(LP Information) projects that Recurrent Glioblastoma Multiforme (GBM) Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Recurrent Glioblastoma Multiforme (GBM) Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Oral Medications
• Temozolomide
• Nitrosoureas Drugs
• Radiation Therapy
• Chemotherapy

Segmentation by application:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Astrazeneca
• Roche
• GlaxoSmithKline
• Merck
• Pfizer
• AngioChem
• Vascular Biogeneics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Recurrent Glioblastoma Multiforme (GBM) Treatment market by identifying its various subsegments.
• Focuses on the key global Recurrent Glioblastoma Multiforme (GBM) Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Recurrent Glioblastoma Multiforme (GBM) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Recurrent Glioblastoma Multiforme (GBM) Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL RECURRENT GLIOBLASTOMA MULTIFORME (GBM) TREATMENT MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2023
  2.1.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size CAGR by Region
2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Segment by Type
  2.2.1 Oral Medications
  2.2.2 Temozolomide
  2.2.3 Radiosensitizers
  2.2.4 Nitrosoureas Drugs
  2.2.5 Radiation Therapy
  2.2.6 Chemotherapy
2.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
  2.3.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
  2.3.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate by Type (2013-2018)
2.4 Recurrent Glioblastoma Multiforme (GBM) Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Ambulatory Surgical Centers
2.5 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
  2.5.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
  2.5.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate by Application (2013-2018)

3 GLOBAL RECURRENT GLIOBLASTOMA MULTIFORME (GBM) TREATMENT BY PLAYERS

3.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Players
  3.1.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Players (2016-2018)
  3.1.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Players (2016-2018)
3.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECURRENT GLIOBLASTOMA MULTIFORME (GBM) TREATMENT BY REGIONS

4.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions
4.2 Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth
4.3 APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth
4.4 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth
4.5 Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth

5 AMERICAS

5.1 Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Countries
5.2 Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
5.3 Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Countries
6.2 APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
6.3 APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment by Countries
7.2 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
7.3 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment by Countries
8.2 Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
8.3 Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL RECURRENT GLIOBLASTOMA MULTIFORME (GBM) TREATMENT MARKET FORECAST

10.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2023)
10.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Forecast by Regions
  10.2.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Forecast by Type
10.8 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Astrazeneca
  11.1.1 Company Details
  11.1.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.1.3 Astrazeneca Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Astrazeneca News
11.2 Roche
  11.2.1 Company Details
  11.2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.2.3 Roche Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Roche News
11.3 GlaxoSmithKline
  11.3.1 Company Details
  11.3.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.3.3 GlaxoSmithKline Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 GlaxoSmithKline News
11.4 Merck
  11.4.1 Company Details
  11.4.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.4.3 Merck Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Merck News
11.5 Pfizer
  11.5.1 Company Details
  11.5.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.5.3 Pfizer Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Pfizer News
11.6 AngioChem
  11.6.1 Company Details
  11.6.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.6.3 AngioChem Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 AngioChem News
11.7 Vascular Biogeneics
  11.7.1 Company Details
  11.7.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Product Offered
  11.7.3 Vascular Biogeneics Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Vascular Biogeneics News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Recurrent Glioblastoma Multiforme (GBM) Treatment
Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate 2013-2023 ($ Millions)
Table Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Oral Medications
Table Major Players of Temozolomide
Table Major Players of Radiosensitizers
Table Major Players of Nitrosoureas Drugs
Table Major Players of Radiation Therapy
Table Major Players of Chemotherapy
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Figure Global Oral Medications Market Size Growth Rate
Figure Global Temozolomide Market Size Growth Rate
Figure Global Radiosensitizers Market Size Growth Rate
Figure Global Nitrosoureas Drugs Market Size Growth Rate
Figure Global Radiation Therapy Market Size Growth Rate
Figure Global Chemotherapy Market Size Growth Rate
Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Consumed in Hospitals
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Consumed in Clinics
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Consumed in Ambulatory Surgical Centers
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market: Ambulatory Surgical Centers (2013-2018) ($ Millions)
Figure Global Ambulatory Surgical Centers YoY Growth ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size in Hospitals Growth Rate
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size in Clinics Growth Rate
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size in Ambulatory Surgical Centers Growth Rate
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Players (2016-2018) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Players (2016-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Players in 2017
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players Head office and Products Offered
Table Recurrent Glioblastoma Multiforme (GBM) Treatment Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions 2013-2018 ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Regions 2013-2018
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Regions 2013-2018
Figure Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 ($ Millions)
Figure APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 ($ Millions)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 ($ Millions)
Table Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries (2013-2018)
Figure Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries in 2017
Table Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) ($ Millions)
Table Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Figure Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type in 2017
Table Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) ($ Millions)
Table Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application in 2017
Figure United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Canada Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Table APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Countries (2013-2018) ($ Millions)
Table APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries (2013-2018)
Figure APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries in 2017
Table APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) ($ Millions)
Table APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Figure APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type in 2017
Table APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) ($ Millions)
Table APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application in 2017
Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Korea Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Australia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries in 2017
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) ($ Millions)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type in 2017
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) ($ Millions)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application in 2017
Figure Germany Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure France Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure UK Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Italy Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Russia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Spain Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Countries in 2017
Table Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type in 2017
Table Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application in 2017
Figure Egypt Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Israel Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment arket Size Forecast (2018-2023) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share Forecast by Regions
Figure Americas Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure APAC Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Canada Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Mexico Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Brazil Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Korea Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Australia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Germany Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure France Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure UK Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Italy Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Russia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Spain Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Egypt Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure South Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Israel Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure Turkey Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Figure GCC Countries Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2018-2023 ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share Forecast by Type (2018-2023)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share Forecast by Application (2018-2023)
Table Astrazeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astrazeneca Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure Astrazeneca Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure Roche Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Head Office, Major Market Areas and Its Competitors
Table GlaxoSmithKline Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure GlaxoSmithKline Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure Merck Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure Pfizer Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)
Table AngioChem Basic Information, Head Office, Major Market Areas and Its Competitors
Table AngioChem Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure AngioChem Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)
Table Vascular Biogeneics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vascular Biogeneics Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Gross Margin (2016-2018)
Figure Vascular Biogeneics Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2016-2018)